Comorbidity, hypoglycaemia and appropriate selection of antidiabetic pharmacotherapy in diabetic patients with heart failure in clinical practice in Germany

@article{Gitt2012ComorbidityHA,
  title={Comorbidity, hypoglycaemia and appropriate selection of antidiabetic pharmacotherapy in diabetic patients with heart failure in clinical practice in Germany},
  author={Dr. A.K. Gitt and Peter Bramlage and Christiane Binz and Michael Krekler and Evelin Deeg and Diethelm Tschoepe},
  journal={Herz},
  year={2012},
  volume={37},
  pages={294-300}
}
Patients with type 2 diabetes and heart failure are considered to be at high risk for hypoglycaemic complications. There is a considerable uncertainty with respect to the appropriate choice of antidiabetic pharmacotherapy in patients with type 2 diabetes and comorbid heart failure. Little is known about comorbidity, hypoglycaemia rates and selected pharmacotherapy in diabetic patients with heart failure in clinical practice. DiaRegis is a prospective registry in Germany including 3,810 patients… CONTINUE READING